Cintas (CTAS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
26 Oct, 2026Voting matters and shareholder proposals
Annual meeting scheduled for Oct. 28, 2025, at 11:30 a.m. ET; voting deadline Oct. 27, 2025, at 11:59 p.m. ET, or Oct. 23 for plan-held shares.
Board recommends voting For all nine director nominees: Melanie W. Barstad, Beverly K. Carmichael, Karen L. Carnahan, Robert E. Coletti, Scott D. Farmer, Martin Mucci, Joseph Scaminace, Todd M. Schneider, and Ronald W. Tysoe.
Board recommends For advisory approval of named executive officer compensation and ratification of Ernst & Young LLP as independent auditor for FY2026.
Shareholder proposal seeks the ability to call a special shareholder meeting; Board recommends Against.
Board of directors and corporate governance
Nine directors are standing for election at the 2025 annual meeting.
Executive compensation and say-on-pay
Shareholders will vote on advisory approval of named executive officer compensation; Board recommends For.
Latest events from Cintas
- Board and governance votes passed, while the majority-vote proposal failed; UniFirst review continues.CTAS
AGM 2026 - Agenda paired three supermajority-rule amendments with board opposition to two shareholder proposals.CTAS
Proxy Filing - Board backed all director nominees and annual pay votes, but opposed DEI and climate proposals.CTAS
Proxy Filing - Board backed nominees, pay, equity plan, and auditor; opposed three disclosure proposals.CTAS
Proxy Filing - Record Q1 growth lifted margins and prompted higher FY27 revenue and adjusted EPS guidance.CTAS
Q1 2027 - Record growth, strategic investments, and key governance changes headline this year's proxy.CTAS
Proxy filing - Virtual annual meeting to vote on directors, pay, auditor, reincorporation, and governance.CTAS
Proxy filing - Record growth, Delaware reincorporation, and strong governance highlight this year's proxy.CTAS
Proxy filing - Record revenue and margin growth in 2026; strong 2027 outlook with continued investment.CTAS
Q4 2026